DALLAS, Texas — August 27, 2025 — Leads & Copy — John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), will headline the 2025 iC³® Life Science & Healthcare Innovation Summit, according to BioNTX, the leading biotechnology and healthcare innovation trade organization in North Texas. The summit is scheduled for September 16–17 at the Hilton Anatole in Dallas, Texas.
Crowley is known for his leadership in rare disease drug development and advocacy for patient-centered innovation. His keynote will focus on how today’s breakthroughs are shaping tomorrow’s biotech landscape.
Entering its second decade, the iC³® Summit brings together entrepreneurs, researchers, investors, and policymakers to co-create the future of life sciences and healthcare. The summit will spotlight Artificial Intelligence (AI) and its impact across the biosciences.
iC³® 2025 Summit highlights include remarks by BIO CEO John Crowley, immersive panel sessions on biosecurity, biotech in space, capital strategies, biomanufacturing, funding, cell & gene therapy, workforce development, and company presentations.
With over 1,000 attendees expected, iC³® 2025 will showcase North Texas as a bioscience and healthcare hub.
Kathleen M. Otto-Rosenblum, CEO of BioNTX, stated that the summit signals that North Texas is at the heart of a nationwide innovation renaissance.
Sponsorship and registration opportunities are available. Visit the website for more details.
Contact: Eric B. Moore, BioNTX, 972-679-6056, emoore@biontx.org
Source: BioNTX
